Calès P, Calès V, Oksman F, Vinel J P, Pascal J P
Service d'Hépato-Gastro-Entérologie, Centre hospitalier universitaire Purpan, Toulouse.
Presse Med. 1988 Apr 23;17(15):742-5.
The aetiological significance of antimitochondrial antibodies (anti-M) being debated, we conducted an aetiological study of 111 sera with anti-M2 antibodies from patients living in the Midi-Pyrénées region (South-West France); these anti-M2 antibodies had been detected in the years 1984-85. Fifty-nine percent of the patients had primary biliary cirrhosis (41 p. 100 were asymptomatic, and 6 p. 100 had normal liver function tests). Anti-M2 antibodies at a titer of 1/500 or more were significantly more frequent among these patients as compared with the others (P less than 0.001, probability = 0.73). Six percent of the patients had chronic active hepatitis. The incidence of primary biliary cirrhosis could be estimated at 8.5 per 10(6) people per annum. In this patient population, primary biliary cirrhosis was more common than all other causes of anti-M2 antibodies, and an anti-M2 titer of 1/500 or more had a 73 p. 100 predictive value for that disease. In the region concerned the incidence of primary biliary disease was higher than previously reported in Western Europe.
鉴于抗线粒体抗体(抗-M)的病因学意义存在争议,我们对来自法国西南部米迪-比利牛斯地区的111例有抗-M2抗体的患者血清进行了病因学研究;这些抗-M2抗体是在1984 - 1985年检测到的。59%的患者患有原发性胆汁性肝硬化(41%无症状,6%肝功能检查正常)。与其他患者相比,这些患者中抗-M2抗体滴度为1/500或更高的情况明显更常见(P<0.001,概率 = 0.73)。6%的患者患有慢性活动性肝炎。原发性胆汁性肝硬化的发病率估计为每年每10^6人中有8.5例。在这一患者群体中,原发性胆汁性肝硬化比抗-M2抗体的所有其他病因更常见,抗-M2滴度为1/500或更高对该病的预测价值为73%。在相关地区,原发性胆汁性疾病的发病率高于西欧此前报道的发病率。